Search and analyze individual stocks with comprehensive metrics
Sicagen India
Fundamental Score
Sicagen India Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SICAGEN across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 17.99 vs Industry: 39.45)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Excellent EPS Growth (113.82% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (113.82% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹108.10 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (60.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Below-Average Return on Equity (3.41%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.57%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (3.07%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Revenue Contraction (-11.93%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Institutional Interest (FII+DII: 3.43%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Trading & Distributors sector...
Financial Statements
Comprehensive financial data for Sicagen India
About SICAGEN
Company Details
Market Information
Performance
SICAGEN Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of SICAGEN?
SICAGEN is currently trading at ₹69.20 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of SICAGEN shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of SICAGEN and what does it mean?
SICAGEN has a P/E ratio of 17.99x compared to the industry average of 39.45x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹18 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is SICAGEN performing according to Bull Run's analysis?
SICAGEN has a Bull Run fundamental score of 43.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 3.41%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does SICAGEN belong to?
SICAGEN operates in the Commercial Services & Supplies industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Sicagen India. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for SICAGEN?
SICAGEN has an ROE of 3.41%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Sicagen India generates profits from shareholders' equity. An ROE of 3% means the company generates ₹3 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is SICAGEN's debt-to-equity ratio and what does it indicate?
SICAGEN has a debt-to-equity ratio of 0.31, which indicates moderate leverage that should be monitored. This means the company has ₹31 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.
What is SICAGEN's dividend yield and is it a good dividend stock?
SICAGEN offers a dividend yield of 1.45%, which means you receive ₹1.45 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has SICAGEN grown over the past 5 years?
SICAGEN has achieved 5-year growth rates of: Sales Growth 5.00%, Profit Growth 113.82%, and EPS Growth 113.82%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in SICAGEN and why does it matter?
Promoters hold 60.39% of SICAGEN shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does SICAGEN compare with its industry peers?
SICAGEN trades at P/E 17.99x vs industry average 39.45x, with ROE of 3.41% and ROCE of 5.57%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether SICAGEN is outperforming its competitive set in profitability, growth, and valuation metrics.
What is SICAGEN's market capitalization and what category does it fall into?
SICAGEN has a market capitalization of ₹274 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for SICAGEN?
Key ratios for SICAGEN: ROE 3.41% (Needs improvement), ROCE 5.57%, P/E 17.99x, Debt-to-Equity 0.31, Interest Coverage 2.91x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is SICAGEN stock and what is its beta?
SICAGEN has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for SICAGEN?
SICAGEN has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹69.20, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in SICAGEN?
Key risks for SICAGEN include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.31), and operational challenges. The stock has a Fundamental Score of 43.2/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Commercial Services & Supplies include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is SICAGEN's operating profit margin and how has it trended?
SICAGEN has a 5-year average Operating Profit Margin (OPM) of 3.07%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is SICAGEN's quarterly performance in terms of sales and profit growth?
SICAGEN's recent quarterly performance shows YoY Sales Growth of -11.93% and YoY Profit Growth of -5.42%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in SICAGEN?
SICAGEN has FII holding of 2.85% and DII holding of 0.58%, totaling 3.43% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.